HSBC's massive PT hike and double upgrade are powerful bullish signals, but the heavy insider selling and earnings tomorrow create a high-risk, high-reward setup. Traders should watch for earnings confirmation before committing; a beat could trigger a squeeze toward $225+, while a miss could see the stock test $170.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 26 $208.02entry
- T+1 · 6mo ago −4.48%α −4.49% · $198.71
- T+5 · 6mo ago +5.49%α +4.40% · $219.43
- T+20 · 5mo ago +34.14%α +36.41% · $279.04
- T+60 · 3mo ago +14.06%α +11.60% · $237.27
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HSBC double-upgraded MRVL (Marvell Technology) from Hold to Buy on May 26, 2026, with a new price target of $300, up from $85, a 253% increase. The stock currently trades at $196.33, implying 52.8% upside to the new target. HSBC has a 55% accuracy rate on 263 calls with a 5.5% average return, placing it in the above-average tier among firms covering MRVL. The consensus is heavily bullish: 42 of 50 analysts rate Buy or Strong Buy (84%), with only 8 Hold and zero Sell. The mean target is $151.68, median $139.50, high $225, low $85, HSBC's $300 target is 98% above the mean, making it the most bullish on the Street. EPS revisions over the past 30 days are net positive: 5 up vs 1 down for the current fiscal year, and 6 up vs 1 down for next year. Insider selling has been heavy, $13.7M in sales over the past six weeks from C-suite executives, but this is partially offset by three congressional buys totaling $17K-$80K in April. The next earnings report is due May 27, 2026, just one day after this upgrade, adding a timing catalyst. The bottom line: HSBC's contrarian, high-conviction call with a massive PT hike signals a major inflection point, but the proximity to earnings and insider selling warrant caution.
Impact Score
Consensus & Targets
The consensus on MRVL is heavily bullish: 13 Strong Buy, 29 Buy, 8 Hold, 0 Sell, 0 Strong Sell (50 analysts total). 84% of analysts rate the stock a Buy or Strong Buy, with no Sell ratings. HSBC's upgrade aligns with the bullish consensus but at a far more aggressive price target.
Current price: $196.33. Consensus mean target: $151.68 (implied downside of -22.7%). Median: $139.50. High: $225. Low: $85. HSBC's $300 target is 98% above the mean and 33% above the prior high, making it the most bullish call on the Street. The stock already trades above the mean, suggesting the consensus is playing catch-up.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-26 | HSBC | upgrade | Buy | $300.00 |
| 2026-05-26 | Morgan Stanley | maintain | Equal-Weight | $172.00 |
| 2026-05-26 | Susquehanna | maintain | Positive | $230.00 |
| 2026-05-26 | Cantor Fitzgerald | maintain | Neutral | $190.00 |
| 2026-05-22 | Stifel | maintain | Buy | $210.00 |
| 2026-05-21 | Citigroup | maintain | Buy | $215.00 |
| 2026-05-20 | Oppenheimer | maintain | Outperform | $200.00 |
| 2026-05-20 | Wells Fargo | maintain | Overweight | $195.00 |
| 2026-05-19 | Evercore ISI Group | maintain | Outperform | $155.00 |
| 2026-05-15 | TD Cowen | maintain | Hold | $190.00 |
Over the past 30 days, analyst activity is net positive: 1 upgrade (HSBC), 0 downgrades. EPS revisions are trending higher: current fiscal year has 5 upward revisions vs 1 downward in 30 days; next fiscal year has 6 up vs 1 down. Estimates are being revised higher, supporting the bullish thesis.
Firm Track Record: HSBC
HSBC accuracy: 55% on 263 calls | avg return: 5.5%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Deutsche Bank | 67% | 2/3 | -4.9% | top tier |
| Evercore ISI Group | 57% | 4/7 | 2.2% | above average |
| Cantor Fitzgerald | 57% | 4/7 | 10.2% | above average |
| Needham | 56% | 5/9 | 1.3% | above average |
| Morgan Stanley | 56% | 5/9 | 0.6% | above average |
| Loop Capital | 50% | 2/4 | -1.9% | below average |
| Oppenheimer | 50% | 3/6 | 0.8% | below average |
| Wells Fargo | 50% | 3/6 | -5.5% | below average |
| Raymond James | 50% | 1/2 | -0.4% | below average |
| Benchmark | 50% | 4/8 | 3.1% | below average |
HSBC has a 55% accuracy rate on 263 calls with a 5.5% average return, ranking above average among firms covering MRVL. Top-tier firms include Deutsche Bank (67% on 3 calls, -4.9% avg return) and Evercore ISI (57% on 7 calls, +2.2%). Lower-tier firms include Goldman Sachs (40% on 5 calls, -15.9%) and B of A Securities (33% on 6 calls, +8.7%). HSBC's track record is solid but not elite.
Earnings Estimates
Next earnings: May 27, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $0.79 | $0.62 to $0.83 | $2.4B | ↑1 ↓0 |
| +1q | $0.90 | $0.74 to $0.95 | $2.6B | ↑2 ↓0 |
| +1y | $5.45 | $4.00 to $6.18 | $14.9B | ↑2 ↓0 |
| 0y | $3.82 | $3.27 to $4.28 | $10.9B | ↑1 ↓0 |
Cross-Platform Signals
Insider trades show heavy selling: $13.7M in sales over the past six weeks from C-suite executives (CTO, CFO, COO, EVP). This is a bearish signal that diverges from the analyst upgrade. Congressional activity is mildly bullish: three buys totaling $17K-$80K from Reps. Salazar and Donalds in April. Institutional changes are mixed: Norges Bank exited a large position, while Wells Fargo added 95.9% to its stake. Short interest data is unavailable. The insider selling creates a notable divergence with the bullish analyst call.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
50 reports on MRVL
11 of 14 bullish or bearish reports moved the stock their way by T+1. Best: +145.40% at T+60 after the Mar 5, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.40 Now $145.67 +0.19% settles Nov 18
- Nov 13, 20264d ago 3 Neutral 2/10 Entry $156.76 to $145.36 Now $145.67 −7.07% ▼ −7.27% −5.36% vs SPY
- Nov 13, 20264d ago 3 Neutral 2/10 Entry $156.76 to $145.36 Now $145.67 −7.07% ▼ −7.27% −5.36% vs SPY
- Nov 13, 20264d ago 3 Neutral 1/10 Entry $156.76 to $145.36 Now $145.67 −7.07% ▼ −7.27% −5.36% vs SPY
- Nov 12, 20265d ago 8-K Neutral 2/10 Entry $164.45 to $156.76 Now $145.67 −11.42% ▼ −4.68% −4.31% vs SPY
- Nov 5, 202612d ago SC 13G/A Neutral 2/10 Entry $133.55 to $141.20 Now $145.67 +9.08% ▲ +5.73% +5.42% vs SPY
- Nov 3, 202614d ago ANALYST-DOWNGRADE Bearish 6/10 Entry $171.97 to $159.80 Now $145.67 +15.29% ▲ +7.08% +8.73% vs SPY
- Nov 3, 202614d ago ANALYST-DOWNGRADE Bearish 5/10 Entry $171.97 to $159.80 Now $145.67 +15.29% ▲ +7.08% +8.73% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $171.97 to $159.80 Now $145.67 −15.29% ▼ −7.08% −8.73% vs SPY
- Nov 2, 202615d ago 425 Mixed 7/10 Entry $171.41 to $171.97 Now $145.67 −15.02% ▲ +0.33% +0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers